Skip to main content
Log in

Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma

  • Letters to the Editor
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schroeder, S.A., Gaughan, D.M. & Swift, M. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis. Nature Medicine 1, 703–705. (1995).

    Article  CAS  Google Scholar 

  2. Mennie, M.F. et al. Prenatal screening for cystic fibrosis. Lancet 340, 214–217. (1992).

    Article  CAS  Google Scholar 

  3. Meyers, D.A. & Marsh, D.G. Allergy and asthma. in The Genetic Basis of Common Diseases (eds King, R.A., Rotter, J.I. & Motulsky, A.G.) 130 (Oxford University Press, Oxford, 1992).

    Google Scholar 

  4. Capewell, S. Asthma in Scotland: epidemiology and clinical management. Health Bulletin 51, 118–127 (1993).

    CAS  PubMed  Google Scholar 

  5. Livingstone, J. et al. Antenatal screening for cystic fibrosis: A trial of the couple model. Br. Med. J. 308, 1459–1462. (1994).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mennie, M., Gilfillan, A., Brock, D. et al. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1, 978–979 (1995). https://doi.org/10.1038/nm1095-978b

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1095-978b

  • Springer Nature America, Inc.

This article is cited by

Navigation